BioVie Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioVie Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $2.24K.
- BioVie Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $2.24K.
- BioVie Inc. stock issued during period, value, stock options exercised for fiscal 2019 was $19.31K, a 865.45% increase from fiscal 2018.
- BioVie Inc. stock issued during period, value, stock options exercised for fiscal 2018 was $2.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-06-30 | $2.24K 10-K · filed 2024-09-30 | |
| 2022-12-31 | $2.24K 10-Q · filed 2024-05-14 | |
| 2019-06-30 | $19.31K 10-K/A · filed 2020-08-07 | |
| 2018-06-30 | $2.00K 10-K · filed 2019-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |